Why the study?
Intravenous thrombolysis is not guideline-recommended after DOAC intake within 48 hours, but recent observational studies and experimental data suggest its safety.
Is intravenous thrombolysis safe in patients with ischaemic stroke and recent DOAC intake?
Is intravenous thrombolysis safe in patients with ischaemic stroke and recent DOAC intake?
Recent observational data suggest intravenous thrombolysis may be safe in ischaemic stroke patients with recent DOAC intake, potentially challenging current US and European guidelines.
Challenges current guidelines against thrombolysis in recent DOAC users; leaves open need for confirmatory RCTs.
Intravenous thrombolysis is not recommended in anticoagulated patients receiving direct oral anticoagulants (DOACs) and a recent intake within the last 48 hours in US and European guidelines. However, three observational studies now suggest safety of thrombolysis in patients with recent intake of DOACs, and thus support previous experimental data. In this perspective, the current evidence and practical consequences are discussed.
No takes yet. Share an insight, caveat, or question.
Purrucker et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: